Prevalence and risk factors of drug-resistant tuberculosis in border provinces of Iran

References

• Villarino ME, Geiter LJ, Simone PM. The multidrug-resistant tuberculosis challenge to public health efforts to control tuberculosis. Public Health Rep 1992;17:616–25
   Google Scholar
• Masjedi MR, Tabarsi P, Marjani M, Shiva PB, Nasehi M, Gooya MM, et al. Management of MDR-TB: review of Iran’s experience. Tanaffos 2013;12:6–15
   Google Scholar
• Musser JM. Antimicrobial agent resistance in mycobacteria: molecular genetics insights. Clin Microbiol Rev 1995;8:496–514
   PubMed Web of Science ®Google Scholar
• Zhang Y, Telenti A. Genetics of drug resistance in Mycobacterium tuberculosis. In Hatfull GF, Jabobs WR, editors. Molecular genetics of Mycobacteria. Washington, DC: American Society for Microbiology; 2000. pp 235–54
   Google Scholar
• Heym B, Saint-Joanis B, Cole ST. The molecular basis of isoniazid resistance in Mycobacterium tuberculosis. Tubercle Lung Dis 1999;79:267–71
   PubMedGoogle Scholar
• Saint-Joanis B, Souchon H, Wilming M, Johnsson K, Alzari PM, Cole ST. Use of site-directed mutagenesis to probe the structure, function and isoniazid activation of the catalase/peroxidase, KatG, from Mycobacterium tuberculosis. Biochem J 1999;338:753–60
   PubMed Web of Science ®Google Scholar
• Morcillo N, Zumarraga M, Alito A, Dolmann A, Schouls L, Cataldi A, et al. A low cost, homemade, reverse-line blot hybridization assay for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2002;6:959–65
   PubMed Web of Science ®Google Scholar
• Mokrousov I, Otten T, Vyshnevskiy B, Narvskaya O. Allele-specific rpoB PCR assays for detection of rifampin-resistant Mycobacterium tuberculosis in sputum smears. Antimicrob Agents Chemother 2003;47:2231–5
   PubMed Web of Science ®Google Scholar
• Yang Z, Durmaz R, Yang D, Gunal S, Zhang L, Foxman B, et al. Simultaneous detection of isoniazid, rifampin, and ethambutol resistance of Mycobacterium tuberculosis by a single multiplex allele-specific polymerase chain reaction (PCR) assay. Diagn Microbiol Infect Dis 2005;53:201–8
   PubMed Web of Science ®Google Scholar
• World Health Organization Stop TB Department, World Health Organization. 7th Meeting of the Strategic and Technical Advisory Group for Tuberculosis (STAG-TB). Report on Conclusions and Recommendations. Geneva, Switzerland: World Health Organization; 2007
   Google Scholar
• World Health Organization. Policy Statement Molecular Line Probe Assays for Rapid Screening of Patients at Risk of Multidrug-Resistant Tuberculosis (MDR-TB). Geneva, Switzerland: World Health Organization; 2008
   Google Scholar
• Theron G, Peter J, Calligaro G. Use of multiplex allele-specific polymerase chain reaction (MAS-PCR) to detect multidrug-resistant tuberculosis in Panama. PLoS One 2012;7:1–7
   Google Scholar
• Ioannidis P, Papaventsis D, Karabela S, Nikolaou S, Panagi M, Raftopoulou E, et al. Cepheid GeneXpert MTB/RIF assay for Mycobacterium tuberculosis detection and rifampin resistance identification in patients with substantial clinical indications of tuberculosis and smear-negative microscopy results. J Clin Microbiol 2011;49:3068–70
   PubMed Web of Science ®Google Scholar
• Blakemore R, Story E, Helb D, Kop J, Banada P, Owens MR, et al. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol 2010;48:2495–501
   PubMed Web of Science ®Google Scholar
• van Soolingen D, Qian PE, de Haas JT, Douglas JT, Traore H, Portaels F, et al. Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia. J Clin Microbiol 1995;33:3234–8
   PubMed Web of Science ®Google Scholar
• World Health Organization. Anti-tuberculosis drug resistance in the world. In Report No. 4. WHO/HTM/TB/2008.394. Geneva, Switzerland: World Health Organization; 2008. Available from http://whqlibdoc.who.int/hq/2008/who_htm_tb_2008.394_eng.pdf
   Google Scholar
• Taghavi K, Farnia P, Varahram M, Sheikhoslami FM, Ahmadi M, Kazempoor M, et al. Rapid detection of isoniazid resistance in Mycobacterium tuberculosis by a single multiplex allele-specific polymerase chain reaction assay. Cell J 2011;13:97–102
   Web of Science ®Google Scholar
• Chia BS, Lanzas F, Rifat D, Herrera A, Kim EY, Sailer C, et al. Use of multiplex allele-specific polymerase chain reaction (MAS-PCR) to detect multidrug-resistant tuberculosis in Panama. PLoS One 2012;7:1–7
   Google Scholar
• Abdelaal A, El-Ghaffar HA, Zaghloul MH, El Mashad N, Badran E, Fathy A. Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial. Ann Clin Microbiol Antimicrob 2009;30:4
   Google Scholar
• Potdar P, Thakur P. Development of sequence based molecular diagnostic test to evaluate MDR and XDR in M. tuberculosis patients from western India. Am J Infect Dis Microbiol 2013;1:50–8
   Google Scholar
• Zenteno-Cuevas R, Zenteno JC, Cuellar A, Cuevas B, Sampieri CL, Riviera JE, Parissi A. Mutations in rpoB and KatG genes in Mycobacterium isolates from the Southeast of Mexico. Mem Inst Oswaldo Cruz 2009;104:468–72
   PubMed Web of Science ®Google Scholar
• Sajduda A, Brzostek A, Poplawska M, Augustynowicz-Kopec E, Zwolska Z, Niemann S, et al. Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland. J Clin Microbiol 2004;42:2425–31
   PubMed Web of Science ®Google Scholar
• Silva M, Senna S, Ribeiro M, Valim AR, Telles MA, Kritski A, et al. Mutations in KatG, inhA and ahpC genes of Brazilian isoniazid-resistant isolates of Mycobacterium tuberculosis. J Clin Microbiol 2003;41:4471–4
   PubMed Web of Science ®Google Scholar
• Hillemann D, Kubica T, Agzamova R, Venera B, Rüsch-Gerdes S, Niemann S. Rifampicin and isoniazid resistance mutations in Mycobacterium tuberculosis strains isolated from patients in Kazakhstan. Int J Tuberc Lung Dis 2005;9:1161–7
   PubMed Web of Science ®Google Scholar
• Viader-Salvadó JM, Luna-Aguirre CM, Reyes-Ruiz JM, Valdez-Leal R, del Bosque-Moncayo Mde L, Tijerina-Menchaca R, et al. Frequency of mutations in rpoB and codons 315 and 463 of KatG in rifampin- and/or isoniazid-resistant Mycobacterium tuberculosis isolates from Northeast Mexico. Microb Drug Resist 2003;9:33–8
   PubMed Web of Science ®Google Scholar
• Nusrath Unissa A, Selvakumar N, Narayanan S, Narayanan PR. Molecular analysis of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India. Int J Antimicrob Agents 2008;31:71–5
   PubMed Web of Science ®Google Scholar
• Torres M, Criado A, Gónzalez N, Palomares JC, Aznar J. Rifampin and isoniazid resistance associated mutations in Mycobacterium tuberculosis clinical isolates in Seville, Spain. Int J Tuberc Lung Dis 2002;6:160–3
   PubMed Web of Science ®Google Scholar
• Ramaswamy SV, Dou SJ, Rendon A, Yang Z, Cave MD, Graviss EA. Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico. J Med Microbiol 2004;53:107–13
   PubMed Web of Science ®Google Scholar
• Gupta A, Prakash P, Singh SK, Anupurba S. Rapid genotypic detection of rpoB and KatG gene mutations in Mycobacterium tuberculosis clinical isolates from Northern India as determined by MAS-PCR. J Clin Lab Anal 2013;27:31–7
   PubMed Web of Science ®Google Scholar
• Qian L, Abe C, Lin TP, Yu MC, Cho SN, Wang S, Douglas JT. rpoB genotypes of Mycobacterium tuberculosis Beijing family isolates from East Asian countries. J Clin Microbiol 2002;40:1091–4
   PubMed Web of Science ®Google Scholar
• Tracevska T, Jansone I, Broka L, Marga O, Baumanis V. Mutations in the rpoB and KatG genes leading to drug resistance in Mycobacterium tuberculosis in Latvia. J Clin Microbiol 2002;40:3789–92
   PubMed Web of Science ®Google Scholar
• Wang X, Jiao J, Xu W, et al. A simple rapid and economic method for detecting multidrug-resistant tuberculosis. Braz J Infect Dis 2013;17:667–71
   PubMed Web of Science ®Google Scholar
• Yew WW, Leung CC. Management of multidrug-resistant tuberculosis: Update 2007. Respirology 2008;13:21–46
   PubMed Web of Science ®Google Scholar
• Suresh N, Singh UB, Arora J, Pant H, Seth P, Sola C. rpoB gene sequencing and spoligotyping of multidrug-resistant Mycobacterium tuberculosis isolates from India. Infect Genet Evol 2006;6:474–83
   PubMed Web of Science ®Google Scholar
• Prammananan T, Cheunoy W, Taechamahapun D, Yorsangsukkamol J, Phunpruch S, Phdarat P, et al. Distribution of rpoB mutations among multidrug resistant Mycobacterium tuberculosis (MDRTB) strains from Thailand and development of a rapid method for mutation detection. Clin Microbiol Infect 2008;14:446–53
   PubMed Web of Science ®Google Scholar
• Huang H, Jin Q, Ma Y, Chen X, Zhuang Y. Characterization of rpoB mutations in rifampicin resistant Mycobacterium tuberculosis isolated in China. Tuberculosis 2002;82:79–83
   PubMed Web of Science ®Google Scholar
• Umubyeyi AN, Vandebriel G, Gasana M, Basinga P, Zawadi JP, Gatabazi J, et al. Results of a national survey on drug resistance among pulmonary tuberculosis patients in Rwanda. Int J Tuberc Lung Dis 2007;11:189–94
   PubMed Web of Science ®Google Scholar
• Massi MN, Wahyuni S, Halik H, Yusuf I, Leong FJ, Dick T, Phyu S. Drug resistance among tuberculosis patients attending diagnostic and treatment centres in Makassar, Indonesia. Int J Tuberc Lung Dis 2011;15:489–95
   PubMed Web of Science ®Google Scholar
• Merza MA, Farnia P, Tabarsi P, Khazampour M, Masjedi MR, Velayati AA. Anti-tuberculosis drug resistance and associated risk factors in a tertiary level TB center in Iran: a retrospective analysis. J Infect Dev Ctries 2011;5:511–19
   PubMed Web of Science ®Google Scholar
• Mdivani N, Zangaladze E, Volkova N, Kourbatova E, Jibuti T, Shubladze N, et al. High prevalence of multidrug-resistant tuberculosis in Georgia. Int J Infect Dis 2008;12:635–44
   PubMed Web of Science ®Google Scholar